ATE343633T1 - Allele formen von menschlichem stat3 - Google Patents

Allele formen von menschlichem stat3

Info

Publication number
ATE343633T1
ATE343633T1 AT98951396T AT98951396T ATE343633T1 AT E343633 T1 ATE343633 T1 AT E343633T1 AT 98951396 T AT98951396 T AT 98951396T AT 98951396 T AT98951396 T AT 98951396T AT E343633 T1 ATE343633 T1 AT E343633T1
Authority
AT
Austria
Prior art keywords
human
status3
allel
forms
autoimmune
Prior art date
Application number
AT98951396T
Other languages
English (en)
Inventor
Ottaviano Serlupi-Crescenzi
Pietra Linda Della
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP97116061A external-priority patent/EP0906953A1/de
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE343633T1 publication Critical patent/ATE343633T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98951396T 1997-09-16 1998-09-15 Allele formen von menschlichem stat3 ATE343633T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97116061A EP0906953A1 (de) 1997-09-16 1997-09-16 Allele Formen von menschlicher STAT3
EP98102774A EP0905234A3 (de) 1997-09-16 1998-02-18 Allele Formen vom Menschlicher STAT3

Publications (1)

Publication Number Publication Date
ATE343633T1 true ATE343633T1 (de) 2006-11-15

Family

ID=26145781

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98951396T ATE343633T1 (de) 1997-09-16 1998-09-15 Allele formen von menschlichem stat3

Country Status (10)

Country Link
US (2) US6369198B1 (de)
EP (2) EP0905234A3 (de)
JP (1) JP2001516578A (de)
AT (1) ATE343633T1 (de)
AU (1) AU9743698A (de)
DE (1) DE69836278T2 (de)
DK (1) DK1012286T3 (de)
ES (1) ES2272010T3 (de)
PT (1) PT1012286E (de)
WO (1) WO1999014322A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391572B1 (en) 1999-08-31 2002-05-21 The Rockefeller University Methods for identifying modulators of transcriptional activator protein interactions
US7094140B2 (en) * 2003-06-03 2006-08-22 Onfloor Technologies, L.L.C. Abrasive sanding surface
US20060148715A1 (en) * 2004-12-20 2006-07-06 Baylor College Of Medicine Structural requirements for STAT3 binding and recruitment to phosphotyrosine ligands
JP5495249B2 (ja) * 2009-02-23 2014-05-21 富士通株式会社 新規化合物、リン酸化阻害剤、インスリン抵抗性改善剤、及び糖尿病の予防乃至治療剤、並びに、スクリーニング方法
US20130177979A1 (en) * 2010-06-22 2013-07-11 University Of Central Florida Research Foundation, Inc. Methods and compositions for cell permeable stat3 inhibitor
EP2723892A2 (de) * 2011-06-27 2014-04-30 Galderma Research & Development Neue th-17-differenzierungsmarker für rosacea und ihre verwendung
AU2019321449A1 (en) * 2018-08-15 2021-04-01 The Regents Of The University Of California IL-10 inhibition for vaccines and immunotherapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09506243A (ja) * 1993-09-24 1997-06-24 ザ ロックフェラー ユニヴァーシティ レセプター認識因子、蛋白配列およびその使用方法
EP0676469A3 (de) * 1994-04-04 1998-03-25 Tadamitsu Kishimoto Transkriptionsfaktor APRF
US5716622A (en) * 1995-01-06 1998-02-10 The Rockefeller University Functionally active regions of signal transducer and activators of transcription

Also Published As

Publication number Publication date
JP2001516578A (ja) 2001-10-02
EP1012286A2 (de) 2000-06-28
EP0905234A2 (de) 1999-03-31
EP0905234A3 (de) 1999-06-23
US20030166854A1 (en) 2003-09-04
WO1999014322A2 (en) 1999-03-25
EP1012286B1 (de) 2006-10-25
PT1012286E (pt) 2006-12-29
ES2272010T3 (es) 2007-04-16
DE69836278T2 (de) 2007-09-13
DK1012286T3 (da) 2007-02-12
AU9743698A (en) 1999-04-05
WO1999014322A3 (en) 1999-08-05
US6660848B2 (en) 2003-12-09
US6369198B1 (en) 2002-04-09
DE69836278D1 (de) 2006-12-07

Similar Documents

Publication Publication Date Title
ATE531382T1 (de) Behandlungsmethoden von entzündungskrankheiten mit spezifisch an menschliches angiopoietin-2 bindenden wirkstoffen
FI963101L (fi) Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut
DK1025124T3 (da) Human interferon-alfa-analoge med lav toksicitet
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE232396T1 (de) Oxydiertes thymosin beta 4
ES2154741T3 (es) Uso de agentes de union a cd23 en el tratamiento de enfermedades autoinmunes.
DE69017874D1 (de) EPROM-Anordnung mit metallenen Source-Anschlüssen und ihre Herstellung.
SE9802729D0 (sv) Novel Compounds
IS2819B (is) Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra
NO20006113D0 (no) Anvendelse av cyklosporiner i behandlingen av inflammatoriske autoimmune sykdommer
DE60304695D1 (de) 7-ARYLSULFONAMID-2,3,4,5-TETRAHYDRO-1H-BENZOiDöAZEPINE MIT 5-HT6 REZEPTOR AFFINITÄT ZUR BEHANDLUNG VON ZENTRALNERVENSYSTEMERKRANKUNGEN
ATE343633T1 (de) Allele formen von menschlichem stat3
DK1040191T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
ATE254595T1 (de) 2-amino-6-methyl-7-acetyl-tetralin und pharmazeutische zusammensetzungen zur vorbeugung und therapeutischen behandlung von entzündlichen und/oder autoimmunkrankheiten
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
ATE398134T1 (de) Neue analoga von nitrobenzylthioinosin
EP1507523A4 (de) Zimtsäure-dimere, ihre herstellung und verwendung zur behandlung von neurodegenerativen erkrankungen
BG101846A (bg) Варианти на човешка дезоксирибонуклеаза i
PT1496884E (pt) Associacao de um antitrombotico e de aspirina e sua utilizacao no tratamento das doencas tromboticas aterosclerosas.
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
BR9812489A (pt) Uso de 6,7-substituìdas-2-aminotetralinas adequadas para a preparação de uma composição farmacêutica para o tratamento terapêutico de patologias inflamatórias e/ou autoimunes
DE59811703D1 (de) Medizinischer oder dentalmedizinischer Behandlungsstuhl
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
WO2000027881A3 (de) Menschliche interleukin -10 mutantenproteine
WO2002000835A3 (fr) Nouveau polypeptide, proteine de transcription humaine 23, et polynucleotide codant ce polypeptide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1012286

Country of ref document: EP

REN Ceased due to non-payment of the annual fee